PHARMAKNOWLEDGE ApS: Financial statements 2024
CVR: 30523202
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PHARMAKNOWLEDGE ApS (CVR 30523202) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -5,161 and a net result of DKK 47,554 compared with DKK 37,740 the year before. Equity in the 2024 report amounted to DKK 525,980. The solvency ratio was 98.9%.
- Gross Profit
- DKK -5,161
- Profit/Loss
- DKK 47,554
- Equity
- DKK 525,980
- Total Assets
- DKK 531,671
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -5K | 48K | 526K | - |
| 2023 | - | -5K | 38K | 478K | - |
| 2022 | - | -4K | -61K | 441K | - |
| 2021 | - | 23K | 56K | 502K | - |
| 2020 | - | -4K | 18K | 496K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PHARMAKNOWLEDGE ApS has published its annual report for 2023. Gross profit came to DKK -4,716, and the net result was DKK 37,740.
About PHARMAKNOWLEDGE ApS
PHARMAKNOWLEDGE ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2008. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Lene Worsaae Dalby. The company is owned by Lene Worsaae Dalby. The company has 1 employee (2011). In 2025, the company reported a gross profit of DKK -5,254 and a net result of DKK 20,016 compared with DKK 47,554 the year before. Equity in the 2025 report amounted to DKK 545,996.